Mika Lindvall
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Mechanisms and Therapy, Synthesis and biological activity, Computational Drug Discovery Methods, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → A Critical Assessment of Docking Programs and Scoring Functions(2005)1,688 cited
- → Towards the sustainable discovery and development of new antibiotics(2021)1,114 cited
- → Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers(2014)111 cited
- → Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor(2015)103 cited
- → Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery(2012)83 cited
- → Discovery of Potent and Selective RSK Inhibitors as Biological Probes(2015)83 cited
- → Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers(2014)76 cited
- → Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies(2015)74 cited
- → Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors(2008)71 cited
- → Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases(2011)62 cited